#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myelodysplastic syndrome Desmoid tumour Thalassaemia beta Deafness bilateral PIK3CA related overgrowth spectrum Epilepsy with myoclonic-atonic seizures Philadelphia positive acute lymphocytic leukaemia Follicle centre lymphoma follicular grade I, II – III Intracranial calcification Candida infection Fibrosarcoma metastatic Craniopharyngioma Multiple system atrophy Homocystinuria HER2 gene amplification More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Mitochondrial myopathy – Trials in Disease Prader-Willi syndrome – Basic Information Glycogen storage disease type V – Diagnostics Haemophilia A without inhibitors – Life with Disease Marfan’s syndrome – Trials in Disease Hereditary optic atrophy – Basic Information Synovial sarcoma metastatic – Diagnostics Gastrointestinal stromal tumour – Trials in Disease Toxic epidermal necrolysis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Loratadine Sorafenib Metamizole Dexamethasone Ph. Eur. Lenograstim Atorvastatin Vudalimab Betula Verrucosa Pollen Cetrimide AMODIAQUINE Padeliporfin DUVELISIB Eptacog Beta (Activated) PHENTOLAMINE MESILATE Izokibep Mitoxantrone Tezacaftor Ligelizumab Frexalimab Telitacicept More therapies…

    Learn about Your Condition

    Shprintzen-Goldberg syndrome Prostate cancer metastatic Renal cell carcinoma Electronic cigarette user Univentricular heart Atopic keratoconjunctivitis Breast angiosarcoma metastatic Conjunctivitis allergic Sciatica Inclusion body myositis Toxic epidermal necrolysis Body mass index increased Habitual abortion Cytokine release syndrome Immunodeficiency congenital More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Iceland

  • Study on the Safety and Effectiveness of Quizartinib for Children with Newly Diagnosed FLT3-ITD Positive AML and Normal NPM1

    Recruiting

    2 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Quizartinib Dihydrochloride
    Belgium Denmark Estonia Finland Iceland Latvia +6

  • Study on Apixaban for Preventing Stroke in Patients with Atrial Fibrillation and Stage 5 Chronic Kidney Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • End stage renal disease
    • Chronic kidney disease
    • Atrial fibrillation
    Investigated Drugs:
    • Apixaban
    Finland France Iceland The Netherlands Norway Poland +1

  • Study on Tioguanine and Drug Combination for Patients Aged 0-45 with Newly Diagnosed Acute Lymphoblastic Leukemia

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Prednisolone Sodium Succinate
    • Tioguanine
    • Inotuzumab Ozogamicin
    Belgium Denmark Estonia Finland France Germany +8

  • Long-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial

    Recruiting

    3 1 1
    Investigated Diseases:
    • Arteriosclerosis
    Investigated Drugs:
    • Pelacarsen
    Austria Belgium Bulgaria Czechia Denmark France +14

  • Comparing 7-Day and 4-Week Esomeprazole Treatment in Patients with Unexplained Dyspepsia

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Dyspepsia
    Investigated Drugs:
    • MAGNESIUM CARBONATE HEAVY
    • Calcium Carbonate
    • Esomeprazole
    Iceland

  • Study on Treating Smoldering and Active Multiple Myeloma with Dexamethasone, Lenalidomide, and Carfilzomib for Patients in Iceland

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Carfilzomib
    • Dexamethasone
    • Lenalidomide
    Iceland
Previous Page
1 2 3 4 5
Next Page

Find Clinical Trials in Your Selected Region and City

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Acetylcysteine Amide Cytarabine Pelacarsen Aficamten Lenalidomide Dexamethasone Prednisolone Sodium Succinate Methotrexate Inotuzumab Ozogamicin Evolocumab Vincristine Sulfate Tocilizumab Daunorubicin Hydrochloride Enoxaparin Sodium Mercaptopurine Olaparib 1-{6-[(4M)-4-(5-Chloro-6-Methyl-1H -Indazol-4-Yl)-5-Methyl-3-(1-Methyl-1H -Indazol-5-Yl)-1H -Pyrazol-1-Yl]-2-Azaspiro[3.3]Heptan-2-Yl}Prop-2-En-1-One Hydrocortisone Human Albumin Solution Hydrocortisone Sodium Phosphate Triamcinolone Hexacetonide Prednisone Docetaxel Methylprednisolone Tafasitamab Blinatumomab Certolizumab Pegol Secukinumab Terbinafine Etoposide Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acute lymphocytic leukaemia Acute myeloid leukaemia Arteriosclerosis Atrial fibrillation Bladder transitional cell carcinoma Breast cancer Cerebral amyloid angiopathy Chronic kidney disease Coronary artery disease Dyslipidaemia Dyspepsia End stage renal disease Follicular lymphoma Hypertrophic cardiomyopathy Infertility Intensive care Non-small cell lung cancer Plasma cell myeloma Primary biliary cholangitis Rheumatoid arthritis Small cell lung cancer extensive stage Transitional cell carcinoma

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!